Puma Biotechnology, Inc. (PBYI)

Puma Biotechnology Revenue

In the year 2023, Puma Biotechnology had annual revenue of $235.64M with 3.34% growth. Revenue in the quarter ending December 31, 2023 was $72.18M with 9.90% year-over-year growth.

• Revenue (ttm): $235.64M
• Revenue Growth: +3.34%
• P/S Ratio: 1.03
• Revenue / Employee: $1,273,714
• Employees: 185
• Market Cap: 242.00M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	235.64M	7.61M	3.34%
Dec 31, 2022	228.03M	-25.12M	-9.92%
Dec 31, 2021	253.16M	28.05M	12.46%
Dec 31, 2020	225.11M	-47.15M	-17.32%
Dec 31, 2019	272.26M	21.27M	8.47%
Dec 31, 2018	250.99M	223.31M	806.60%
Dec 31, 2017	27.69M	-	-
Dec 31, 2016	0	-	-
Dec 31, 2015	0	-	-
Dec 31, 2014	0	-	-
Dec 31, 2013	0	-	-
Dec 31, 2012	0	-	-
Dec 31, 2011	0	-	-
Dec 31, 2010	0	-	-
Dec 31, 2009	0	-	-
Dec 31, 2008	0	-	-
Dec 31, 2007	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.